387 related articles for article (PubMed ID: 18068004)
1. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
Kazderova M; Jancova E; Rysava R; Merta M; Tesar V
Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients.
Pisoni CN; Sanchez FJ; Karim Y; Cuadrado MJ; D'Cruz DP; Abbs IC; Khamasta MA; Hughes GR
J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
Lourdudoss C; Vollenhoven Rv
Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
Weng MY; Weng CT; Liu MF
Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
[TBL] [Abstract][Full Text] [Related]
7. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
Dittrich K; Ross S; Benz K; Amann K; Dötsch J
Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
Koukoulaki M; Jayne DR
Nephron Clin Pract; 2006; 102(3-4):c100-7. PubMed ID: 16286784
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
Dall'Era M
Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in lupus nephritis.
Ginzler EM; Aranow C
Lupus; 2005; 14(1):59-64. PubMed ID: 15732290
[TBL] [Abstract][Full Text] [Related]
14. Lupus nephritis: treatment with mycophenolate mofetil.
Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil treatment in children and adolescents with lupus.
Kazyra I; Pilkington C; Marks SD; Tullus K
Arch Dis Child; 2010 Dec; 95(12):1059-61. PubMed ID: 20810399
[TBL] [Abstract][Full Text] [Related]
16. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
Mok CC; To CH; Yu KL; Ho LY
Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much?
Beimler JH; Andrassy K
Pediatr Nephrol; 2004 Sep; 19(9):949-55. PubMed ID: 15257454
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.
Hu W; Liu Z; Chen H; Tang Z; Wang Q; Shen K; Li L
Chin Med J (Engl); 2002 May; 115(5):705-9. PubMed ID: 12133539
[TBL] [Abstract][Full Text] [Related]
19. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
Abe Y; Tada K; Yamaji K; Tamura N
Biomed Res Int; 2021; 2021():8630596. PubMed ID: 33564682
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.
Tanaka S; Kawaguchi T; Kudo R; Kimura M; Rikitake Y; Iwao C; Rikitake M; Iwao K; Aizawa A; Kariya Y; Matsuda M; Miyauchi S; Takajo I; Umekita K
Intern Med; 2022 Oct; 61(20):3131-3135. PubMed ID: 35283391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
